Ultra-low-dose estradiol and dydrogesterone: a phase III study for vasomotor symptoms in China.

M RenX RuanL GuC Pexman-FiethE KahlerQi Yu

Published in: Climacteric : the journal of the International Menopause Society (2021)

Continuous combined estradiol 0.5 mg + dydrogesterone 2.5 mg reduced hot flushes in postmenopausal women in China. This ultra-low-dose regimen provides an additional option for women experiencing the vasomotor symptoms of menopause. These data are consistent with previous results in other populations.

Keyphrases

postmenopausal women
low dose
phase iii
bone mineral density
high dose
open label
clinical trial
high resolution
estrogen receptor
sleep quality
polycystic ovary syndrome
double blind
electronic health record
phase ii
big data
machine learning
type diabetes
skeletal muscle
deep learning